Shapiro Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59M Buy
651,964
+90,330
+16% +$8.29M 3.68% 9
2025
Q4
$50.5M Sell
561,634
-203,854
-27% -$19.3M 2.67% 19
2025
Q3
$75.4M Buy
765,488
+15,600
+2% +$1.55M 3.27% 11
2025
Q2
$68.4M Sell
749,888
-107,868
-13% -$10.4M 3% 16
2025
Q1
$97.1M Sell
857,756
-87,371
-9% -$9.35M 4% 7
2024
Q4
$99.8M Sell
945,127
-55,133
-6% -$5.92M 3.39% 9
2024
Q3
$108M Sell
1,000,260
-28,101
-3% -$3.07M 3.37% 15
2024
Q2
$112M Buy
1,028,361
+106,855
+12% +$12.6M 3.38% 11
2024
Q1
$122M Sell
921,506
-71,034
-7% -$8.87M 3.27% 12
2023
Q4
$121M Buy
+992,540
New +$111M 3.34% 13

Other funds holding ZBH

Shapiro Capital Management's ZBH Position: Q1 2026 in Review

Shapiro Capital Management increased its Zimmer Biomet (ZBH) stake by 16% in Q1 2026, buying an estimated $8.29M and bringing the position to 651,964 shares worth $59M. The position accounts for 3.68% of the portfolio, ranked #9.

Shapiro Capital Management first reported a position in ZBH in Q4 2023 and has held it in 10 quarters since. The position peaked at $122M in Q1 2024. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Shapiro Capital Management held 651,964 shares of Zimmer Biomet worth $59M as of Q1 2026.
  • Shapiro Capital Management bought 90,330 Zimmer Biomet shares in Q1 2026, an estimated $8.29M.
  • Zimmer Biomet made up 3.68% of Shapiro Capital Management's portfolio in Q1 2026, its #9 holding.
  • Shapiro Capital Management first reported a position in Zimmer Biomet in Q4 2023 and has held it in 10 quarters since.
  • Shapiro Capital Management's Zimmer Biomet position peaked at $122M in Q1 2024.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Shapiro Capital Management's 13F filing for Q1 2026, filed 15 May 2026.